Part 2 of GLP-1s: The Growing Ecosystem Breaking down the changing consumer behaviors, the non-manufacturing companies taking action, and the opportunities GLP-1s are unlocking around weight management New Possibilities Await In part 1 of this series, we outlined what GLP-1s are, why theyre seen as essential, and how theyre impacting the healthcare ecosystem
A consistent skincare routine can help keep your skin barrier healthy
The American Diabetes Association recommends reassessing glycemic control and treatment efficacy after approximately 3 months of therapy at a stable maintenance dose
But the mechanistic rationale is sound, since the NF-kB and cytokine pathways that GLP-1 modulates are directly involved in Hashimoto pathogenesis
In this article, Alessandra (Ale) Vignola, President of Cardiovascular & Metabolic, explores the need for sustainable, patient-first solutions in GLP-1 clinical trials from personalized approaches to behavioral and social support
Recuerda que la L-carnitina es un complemento, no un sustituto de hbitos de vida saludables